NL-OMON27950已完成不适用
A Phase II study evaluating short course radiation therapy, neoadjuvant bevacizumab, capecitabine and oxaliplatin, and radical resection of primary tumor and metastases in primary stage IV rectal cancer.
K. Havenga, M.D. Ph.D.0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •DISEASE CHARACTERISTICS:
- •1. Histologically verified adenocarcinoma of the rectum;
排除标准
- •See inclusion criteria.
研究者
相似试验
进行中（未招募）
2 期
Shortened Course Adjuvant Radiotherapy Following TORSHPV-Associated Oropharyngeal Squamous Cell CarcinomaNCT05714657Abramson Cancer Center at Penn Medicine104
Unknown
1 期
Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate CancerProstate CancerNCT01505075Sunnybrook Health Sciences Centre30
招募中
2 期
SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal CancerRectal CancerLocally AdvancedNCT05576480Ruijin Hospital55
已完成
不适用
A Phase II Study of Short-course Radiotherapy Preoperatively followed by Capecitabine and Oxaliplatin (XELOX) for cT3 Node-positive Lower Rectal Cancerow rectal cancerJPRN-UMIN000023361Cancer Institute Hospital of Japanese Foundation for Cancer Research28
尚未招募
1 期
Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRCMetastatic Colorectal CancerMetastatic Colorectal AdenocarcinomaCRCNCT06195670Zhejiang Cancer Hospital220